|  |
Solid, Semisolid, and Specialty Dosage Forms |
 |
|
 |
Join our Solid, Semisolid, and Specialty Dosage Forms Linked-In Community |
 |
|
Parenterals |
 |
|
 |
Join our Parenterals Linked-In Community |
 |
|
Biological API Manufacturing |
 |
 |
Maciej Frolow/Getty Images |
|
The Promise of Peptoids
Because peptoids are relatively easy to synthesize, have tremendous sequence diversity, and are more proteolytically stable than peptides and proteins, they have significant potential for use as APIs, drug-delivery agents, and in numerous biomedical applications.
|
|
 |
Join our Biological API Manufacturing Linked-In Community |
 |
|
Pharmaceutical Analysis |
 |
|
 |
Join our Pharmaceutical Analysis Linked-In Community |
 |
|
Chemical API Manufacturing |
 |
|
 |
Join our Chemical API Manufacturing Linked-In Community |
 |
|
On-Demand Webcast |
 |
USP Outlook: Key Program Activity for 2013
USP standards for the identity, strength, quality, and purity of medicines are an integral part of drug development and manufacturing. Modernization of USP monographs and development and revisions to General Chapters is a top priority for the USP Pharmacopeial Convention in 2013. In this webcast, USP experts provide the status and progress of these efforts: Monograph Modernization progress; New General Chapter content for Excipients, Analysis of Elemental Impurities, and Microbiology; and the latest on the Medicines Compendium.
Register for the on-demand webcast. |
|
 |
|
Highlights from Pharmaceutical Technology and BioPharm International
Recent articles from Pharmaceutical Technology and BioPharm International
Solid Dosage, Semisolid, and Specialty Dosage Forms
Incorporating Process Analytical Technology Data into Process Control (Pharmaceutical Technology’s Equipment & Processing Report)
A Q&A with Ivo Backx, Siemens Industry Automation Division.

Parenterals
Process Analytical Technology: Advances in PAT for Parenteral Drug Manufacturing (BioPharm International)
Applying QbD and PAT facilitates process understanding in lyophilization.

Pharmaceutical Analysis
Advancing Analytical Testing and Instrumentation for Biopharmaceuticals (BioPharm International)

Chemical API Manufacturing
Implications of Indian Supreme Court Rejection of Novartis Patent for Glivec (Pharmaceutical Technology’s Sourcing and Management)

Biologic API Manufacturing
Outsourcing Nontraditional Protein Expression Systems (Biopharm International, Mar)
Growth is seen in outsourcing on insect- and plant-cell-based bioproduction expression systems.

|
|
 |
|
|
|
|
Perspectives from Cynthia Challener, PhD, editor of the Pharmaceutical Sciences, Manufacturing & Marketplace Report and industry members

|
|
|